New SARS-CoV-2 Antigen Reference Material Kit Launched

LGC has released ACCURUN® SARS-CoV-2 Antigen Reference Material Kit, a new quality measurement tool to support SARS-CoV-2 antigen testing. It is formulated for use with test methods that detect the nucleocapsid (NP) protein of SARS-CoV-2 virus - the target for the majority of the SARS-CoV-2 antigen assays currently on the market. 

The product comprises purified recombinant SARS-CoV-2 NP protein in simulated viral transport media. Offering both positive and negative materials, the kit is designed to support assay installation and monitoring of day-to-day assay performance, providing a complete quality solution for SARS-CoV-2 antigen testing.

Clinical laboratories are increasingly adopting antigen tests as a first line SARS-CoV-2 screening tool. While less accurate than amplification-based molecular tests, most antigen tests offer high specificity paired with a less complex, cost-effective design - making them more amendable to rapid, repeat testing of large populations in a point-of-care environment.

Bharathi Anekella, Executive Vice President and General Manager, LGC Clinical Diagnostics, stated, “We anticipate the demand for SARS-CoV-2 antigen testing to continue to be strong for the coming year, as it has become a preferred testing method for rapid large-scale screening, including back-to-work and back-to-school programs. Adding a quality solution like ACCURUN SARS-CoV-2 Antigen Reference Material Kit to the testing workflow offers a way to increase confidence in the results produced by these types of rapid diagnostics.”

More information online